Hormone Therapy for Locally Advanced Prostate Cancer
- 1 August 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 168 (2) , 546-549
- https://doi.org/10.1016/s0022-5347(05)64676-9
Abstract
Conclusions Hormone therapy for locally advanced prostate cancer is associated with minimal morbidity from the primary tumor and from treatment. All cause survival parallels that reported for integrated hormone and radiation therapy.Keywords
This publication has 19 references indexed in Scilit:
- RACE AND CAUSE SPECIFIC SURVIVAL WITH PROSTATE CANCER: INFLUENCE OF CLINICAL STAGE, GLEASON SCORE, AGE AND TREATMENTJournal of Urology, 2000
- Early results of a prospective study of hormone therapy for patients with locally advanced prostate carcinomaCancer, 1998
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997
- Co-Morbidities and Survival of Men with Localized Prostate Cancer Treated with Surgery or Radiation TherapyJournal of Urology, 1996
- Long-term survival among men with conservatively treated localized prostate cancerPublished by American Medical Association (AMA) ,1995
- Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology groupUrology, 1995
- The role of neoadjuvant hormonal manipulation in localized prostatic cancerCancer, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancerCancer, 1981